“The plasma Tumor Necrosis Factor-α (TNF-α) does not have any correlation with disease activity in rheumatoid arthritis patients treated with disease modifying anti-rheumatic drugs (DMARDs)” (2020) Brazilian Journal of Pharmaceutical Sciences, 56, p. e18551. doi:10.1590/s2175-97902019000418551.